Revamping the ovarian tumour microenvironment with an oncolytic adenovirus yields enhanced tumour-infiltrating lymphocyte anti-tumour activity

被引：0
|
作者：
Santos, J. M. [1 ,2 ,3 ]
Heinio, C. [4 ]
Cervera-Carrascon, V. [1 ,2 ,3 ]
Siurala, M. [5 ]
Quixabeira, D. C. A. [4 ]
De Gruijl, T. [6 ,7 ]
Lassus, H. [1 ,8 ,9 ]
Kanerva, A. [1 ,8 ,9 ]
Hemminki, A. [1 ,2 ,3 ]
机构：
[1] Univ Helsinki, Translat Immunol Res Program, Helsinki, Finland
[2] Univ Helsinki, Dept Oncol, Helsinki, Finland
[3] TILT Biotherapeut, Helsinki, Finland
[4] Univ Helsinki, Canc Gene Therapy Grp, Fac Med, Translat Immunol Res Program, Helsinki, Finland
[5] TILT Biotherapeut Ltd, Helsinki, Finland
[6] Univ Med Ctr Amsterdam, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam, Netherlands
[7] Univ Med Ctr Amsterdam, Canc Ctr Amsterdam, Dept Radiat Oncol, Amsterdam, Netherlands
[8] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland
[9] Helsinki Univ Hosp, Helsinki, Finland
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
149P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
    Gemma L. Owens
    Marcus J. Price
    Eleanor J. Cheadle
    Robert E. Hawkins
    David E. Gilham
    Richard J. Edmondson
    Cancer Immunology, Immunotherapy, 2018, 67 : 1519 - 1531
  • [2] Preselecting tumour-infiltrating lymphocyte subsets to implement adoptive immunotherapy in ovarian cancer
    Salas-Benito, D.
    De Andrea, C.
    Aramendia, J. M.
    Mancheno, U.
    Elizalde, E.
    Conde, E.
    Tamayo, I.
    Guillen, F.
    Jurado, M.
    Minguez, J. A.
    Gonzalez Martin, A.
    Ponz-Sarvise, M.
    Hervas-Stubbs, S.
    ANNALS OF ONCOLOGY, 2019, 30 : 419 - 419
  • [3] Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
    Owens, Gemma L.
    Price, Marcus J.
    Cheadle, Eleanor J.
    Hawkins, Robert E.
    Gilham, David E.
    Edmondson, Richard J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (10) : 1519 - 1531
  • [4] Tumour-infiltrating lymphocyte and histological regression in primary melanoma
    Ribero, Simone
    Torres-Navarro, I.
    Botella-Estrada, R.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2021, 313 (01) : 63 - 64
  • [5] Tumour-infiltrating lymphocyte and histological regression in primary melanoma
    Simone Ribero
    I. Torres-Navarro
    R. Botella-Estrada
    Archives of Dermatological Research, 2021, 313 : 63 - 64
  • [6] Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies
    Autio, K.
    Knuuttila, A.
    Kipar, A.
    Ahonen, M.
    Parviainen, S.
    Diaconu, I.
    Kanerva, A.
    Hakonen, T.
    Vaha-Koskela, M.
    Hemminki, A.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2016, 14 (04) : 395 - 408
  • [7] NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity
    Albertsson, PA
    Basse, PH
    Hokland, M
    Goldfarb, RH
    Nagelkerke, JF
    Nannmark, U
    Kuppen, PJK
    TRENDS IN IMMUNOLOGY, 2003, 24 (11) : 603 - 609
  • [8] The anti-tumour activity of bisphosphonates
    Neville-Webbe, HL
    Holen, I
    Coleman, RE
    CANCER TREATMENT REVIEWS, 2002, 28 (06) : 305 - 319
  • [9] Anti-tumour activity of zoledronic acid
    Clézardin, P
    CANCER TREATMENT REVIEWS, 2005, 31 : S1 - S8
  • [10] Making macrophages with anti-tumour activity
    Crunkhorn, Sarah
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (04) : 253 - 253
12345